Barentz acquires Anshul Life Sciences to strengthen its position in India

Barentz International, a global provider of specialty ingredient solutions, announces the acquisition of Anshul Life Sciences Group in India, a premium life sciences-focused specialty chemicals distributor serving the regulated pharmaceutical, food and nutraceutical, and personal care markets.

With this strategic move, Barentz establishes a life sciences distribution platform in India and strengthens its commitment to providing innovative solutions, technical expertise, and a more innovative range of ingredients to customers and principals across India.

The acquisition underscores Barentz’s commitment to the Indian market and is expected to open up strategic opportunities for growth in India and across the Asia Pacific region. Both companies are committed to ensuring a seamless transition and maintaining the highest standards of value-added services.

The acquisition will further strengthen Barentz’s position in India and build a life sciences distribution platform. Anshul Life Sciences strengthens and complements Barentz India’s pharmaceutical ingredients portfolio with high-quality excipients, APIs and intermediates, and expands its personal care and nutraceuticals product range, and the merger will unlock huge growth potential in the Asia Pacific region

“We are very pleased to welcome Anshul Life Sciences to the Barentz Group. This acquisition consolidates our ambition to further grow in India and across the Asia Pacific region, benefiting our customers and principals by providing a broader portfolio of high-quality pharmaceutical excipients and products and a deeper pool of expertise. Together, we aim to enhance our offerings to better meet the needs of the dynamic Indian market and beyond,” said Marc Duchene, CEO of Barentz Asia Pacific.

Nagarajan Kailasam, CEO of Anshul Life Sciences, said, "Barentz closely aligns with the entrepreneurial spirit and ethics of the founding partners of Anshul Life Science. We are excited to join the Barentz family and begin a collaboration to capture the tremendous potential of the Indian market by providing more comprehensive solutions to our clients and principals in the Indian market and beyond. We look forward to the future and growing international presence that this strategic move will bring to Anshul Life Sciences."